Literature DB >> 8004569

Prognostic factors and significance of chemotherapy in patients with recurrent or metastatic transitional cell cancer of the urinary tract.

L Sengeløv1, C Kamby, G Schou, H von der Maase.   

Abstract

BACKGROUND: Prognostic factors for patients with disseminated transitional cell carcinoma of the urothelium (TCC) has been examined only in patients selected for studies with chemotherapy. This study was performed to determine important prognostic factors in patients with disseminated TCC and evaluate the impact of chemotherapy.
METHODS: The prognostic factors for survival were analyzed in 240 patients with disseminated TCC admitted from 1976 to 1992. Information on prior medical history, baseline variables, and treatment were related to survival after dissemination. Both univariate and multivariate analyses were performed to identify factors of independent importance.
RESULTS: Univariate analyses indicated that performance status; hemoglobin; leukocyte count; platelet count; concentrations of serum creatinine, aspartate aminotransferase, lactate dehydrogenase, and alkaline phosphatase; hydronephrosis; bone metastases; disease extension; and chemotherapy were related significantly to survival. Multivariate analysis demonstrated that a good performance status, a normal alkaline phosphatase concentration, and a normal serum creatinine concentration were independent prognosticators for long survival. When chemotherapy was included in the analysis, it was found to be the most important independent prognostic factor in conjunction with alkaline phosphatase and performance status.
CONCLUSION: This study has established the importance of performance status and alkaline phosphatase as the most important prognostic factors of survival in patients with disseminated TCC regardless of treatment. Chemotherapy was found to be an independent prognostic variable that indicates a possible prolongation of survival in patients receiving chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8004569     DOI: 10.1002/1097-0142(19940701)74:1<123::aid-cncr2820740121>3.0.co;2-t

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Clinicopathological features of recurrence after radical cystectomy for patients with transitional cell carcinoma of the bladder.

Authors:  Ken-ichi Harada; Iori Sakai; Toshifumi Kurahashi; Mototsugu Muramaki; Kazuki Yamanaka; Isao Hara; Hiroshi Eto; Hideaki Miyake
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

2.  Risk stratification model, including preoperative serum C-reactive protein and estimated glomerular filtration rate levels, in patients with upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy.

Authors:  Shuichi Morizane; Tetsuya Yumioka; Noriya Yamaguchi; Toshihiko Masago; Masashi Honda; Takehiro Sejima; Atsushi Takenaka
Journal:  Int Urol Nephrol       Date:  2015-06-24       Impact factor: 2.370

3.  Validation of major prognostic models for metastatic urothelial carcinoma using a multi-institutional cohort of the real world.

Authors:  Satoru Taguchi; Tohru Nakagawa; Yukari Uemura; Akihiko Matsumoto; Yasushi Nagase; Taketo Kawai; Yoshinori Tanaka; Kanae Yoshida; Sachi Yamamoto; Yutaka Enomoto; Yorito Nose; Toshikazu Sato; Akira Ishikawa; Tetsuya Fujimura; Hiroshi Fukuhara; Haruki Kume; Yukio Homma
Journal:  World J Urol       Date:  2015-07-02       Impact factor: 4.226

4.  Preoperative prognostic factors after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma.

Authors:  Shuichi Morizane; Hideto Iwamoto; Toshihiko Masago; Akihisa Yao; Tadahiro Isoyama; Takehiro Sejima; Atsushi Takenaka
Journal:  Int Urol Nephrol       Date:  2012-12-11       Impact factor: 2.370

5.  Survival of patients with advanced urothelial cancer treated with cisplatin-based chemotherapy.

Authors:  S D Fosså; C Sternberg; H I Scher; C H Theodore; B Mead; D Dearnaley; J T Roberts; E Skovlund
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

6.  Prognostic Value of Pre-operative Renal Insufficiency in Urothelial Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Jian Cao; Xiaokun Zhao; Zhaohui Zhong; Lei Zhang; Xuan Zhu; Ran Xu
Journal:  Sci Rep       Date:  2016-10-11       Impact factor: 4.379

7.  Perioperative treatments for resected upper tract urothelial carcinoma: a network meta-analysis.

Authors:  Xiao Yang; Peng Li; Xiaheng Deng; Hongquan Dong; Yidong Cheng; Xiaolei Zhang; Chengdi Yang; Jingyuan Tang; Wenbo Yuan; Xiaoting Xu; Jun Tao; Pengchao Li; Haiwei Yang; Qiang Lu; Min Gu; Zengjun Wang
Journal:  Oncotarget       Date:  2017-01-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.